FDA allows abortion pill to be sent by mail

The FDA on Dec. 17 reversed a critical restriction on abortion access by allowing patients to obtain the hormone-blocking drug mifepristone by mail instead of requiring it to be procured in person. 

Advertisement

Mifepristone, known by the brand name Mifeprex, blocks progesterone, a hormone required to sustain pregnancy. 

The agency’s decision makes medical abortions more accessible to people who have difficulty traveling to a provider or want to terminate a pregnancy at home. Patients who wish to receive abortion pills by mail must have a virtual or in-person visit with a physician who can prescribe and send the medication.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Rethinking Safety and Security in the Healthcare Environment

Thursday, July 23
1:00 PM - 2:00 PM CDT

Presenters: Jon Share, AxonDan Snyder, Advocate HealthKeith Hunter, Wellstar

Advertisement

Next Up in Care Coordination

Advertisement

Comments are closed.